Fluoxetine (drug)

DRUG3 trials

Sponsors

MaineHealth, First Affiliated Hospital of Wenzhou Medical University, Hasanuddin University

Conditions

Adolescent DepressionAnxiety DisordersDepression DisordersFluoxetineHepatobiliary MalignancyMajor Depressive Disorder (MDD)

Phase 2

SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety

RecruitingNCT07174947

First Affiliated Hospital of Wenzhou Medical UniversityAnxiety Disorders, Depression Disorders, Fluoxetine +1

Start: 2025-10-01End: 2027-12-01Target: 240Updated: 2026-03-24

Unknown Phase

Lamotrigine in Treatment Resistant Depression in Adolescents

TerminatedNCT00284791

MaineHealthAdolescent Depression

Start: 2006-01-31End: 2007-02-28Target: 50Updated: 2017-05-17

Magnesium Supplementation With Fluoxetine for Cognitive Function in Depression

CompletedNCT07521358

Hasanuddin UniversityMajor Depressive Disorder (MDD)

Start: 2025-07-01End: 2025-08-01Updated: 2026-04-09